The agencies under Health and Human Services Secretary Robert F. Kennedy are getting squeezed between old-guard staff who object to Trump administration priorities on one side, and prominent conservatives and business interests on the other.
The dynamic is creating a minefield between Make America Healthy Again and deregulation for current leaders and new appointees.
The first Senate-confirmed director of the Centers for Disease Control and Prevention, Susan Monarez, was sworn in by Kennedy Thursday, four months after President Trump suddenly yanked the nomination of former GOP Rep. Dave Weldon, who blamed pharmaceutical industry opposition and pharma-favorite GOP Sen. Bill Cassidy – chairman of the Senate Health, Education, Labor and Pensions Committee, that would have held Weldon’s confirmation hearing.
Just 10 days after his appointment as director of the Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh got an unexpected side gig as acting director of the Center for Biologics Evaluation and Research in the wake of Vinay Prasad’s sudden exit following a rash of attacks by pharma boosters and a conservative influencer.
Click this link for the original source of this article.
Author: Joe Weber
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
